Literature DB >> 50413

Histological subtypes and prognostic problems in meningiomas.

K Jellinger, F Slowik.   

Abstract

The incidence of the various histological subtypes of meningiomas was examined in 1238 patients with surgically treated meningiomas, about 80% arising within the cranial cavity. The histological classification used was that of Courville (1950) and Rubinstein (1972), but "angioblastic" meningiomas were segregated into 3 groups: highly vascularized meningiomas, hemangioblastomas, and hemangiopericytomas. Endotheliomatous and transitional forms constituted 85% of the total (71.5% of intracranial tumors), fibroblastic forms 6.6 and 7.5%, respectively, and highly vascularized (endotheliomatous or transitional) meningiomas 5.2% of the intracranial tumors, while true "angioblastic" meningiomas (hemangioblastomas and hemangiopericytomas) amounted to 2.8% of the total (3.1% of the intracranial tumors). 1.2% were "atypical" (so-called malignant) meningiomas; true meningeal sarcomas were excluded. The incidence of recurrence in patients surviving at least 5 years after apparently complete removal of the tumor was 13% for all sites, and 14.2% for intracranial tumors, but almost twice as high after partial removal. There were no significant differences in the recurrence rate and intervals between first and second operation according to the various histological subtypes of meningiomas, except for hemangiopericytomas which recurred with significantly higher frequency and, together with atypical meningiomas, at much shorter intervals than the others. The prognostic significance of some histological criteria in "non-angiomatous" meningiomas was examined in 211 patients surviving at least 5 years after apparently complete removal of the tumor. Among the recurrences, there was a significantly higher degree of cellularity and increased mitotic rate and, probably, of cortical invasion, while nuclear pleomorphism, increased vascularity, and focal necroses showed no definite differences. The presence of mitotic figures alone appeared to be of no prognostic value. While most recurrent meningiomas did not change their basic morphological type significantly, about 12.5% of the recurrences appeared to have a different rate of growth as suggested by increased cellularity and mitotic rates. In 2 cases an isomorphic (benign) meningioma became a true spindle cell sarcoma.

Entities:  

Mesh:

Year:  1975        PMID: 50413     DOI: 10.1007/bf00312803

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  20 in total

1.  Report on 280 cases of verified parasagittal meningioma.

Authors:  G F HOESSLY; H OLIVECRONA
Journal:  J Neurosurg       Date:  1955-11       Impact factor: 5.115

2.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

3.  The prognosis in meningiomas.

Authors:  K Skullerud; A C Löken
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

4.  [Angioreticulomas of the central nervous system (author's transl)].

Authors:  H J Leu; J R Rüttner
Journal:  Acta Neurochir (Wien)       Date:  1973       Impact factor: 2.216

5.  [Extracranically metastasizing meningiomas].

Authors:  G Fényes; F Slowik
Journal:  Zentralbl Neurochir       Date:  1972

6.  Hemangiopericytoma: ultrastructural study of five cases.

Authors:  H Battifora
Journal:  Cancer       Date:  1973-06       Impact factor: 6.860

7.  The use of tissue culture in differentiation between angioblastic meningioma and hemangiopericytoma.

Authors:  J Muller; J Mealey
Journal:  J Neurosurg       Date:  1971-03       Impact factor: 5.115

8.  The prediction of recurrence in meningiomas.

Authors:  M R Crompton; P C Gautier-Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-02       Impact factor: 10.154

9.  [Ultrastructure of hem- angioblastomas of the central nervous system].

Authors:  P Castaigne; M David; B Pertuiset; R Escourolle; J Poirier
Journal:  Rev Neurol (Paris)       Date:  1968-01       Impact factor: 2.607

10.  Blood group isoantigens in angioblastic meningiomas and hemangioblastomas of the central nervous system.

Authors:  K Jellinger; H Denk
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1974
View more
  46 in total

Review 1.  Tumors of the meninges: proposed modifications of the World Health Organization classification.

Authors:  B W Scheithauer
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry.

Authors:  M L Møller; O Braendstrup
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

3.  Factors influencing meningioma recurrence rate.

Authors:  M Naumann; J Meixensberger
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

4.  The significance of atypical mitoses in malignant meningiomas.

Authors:  A Fabiani; F Trebini; M Favero; B Peres; L Palmucci
Journal:  Acta Neuropathol       Date:  1977-06-15       Impact factor: 17.088

5.  Outcome of 31 intracranial haemangiopericytomas: poor predictive value of cell proliferation indices.

Authors:  V Vuorinen; P Sallinen; H Haapasalo; T Visakorpi; M Kallio; J Jääskeläinen
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

6.  Proliferative potential of meningiomas evaluated by proliferating cell nuclear antigen expression.

Authors:  H Nakabayashi; M Sakaguchi; J Katsuyama; A Hakuba
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 7.  Extracranial metastases of meningioma.

Authors:  B Rawat; A A Franchetto; J Elavathil
Journal:  Neuroradiology       Date:  1995-01       Impact factor: 2.804

8.  Diagnosis of intracranial haemangiopericytomas with angiography and CT scanning.

Authors:  A Servo; J Jääskeläinen; T Wahlström; M Haltia
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

9.  Multifocal clear cell meningioma in the spine: a case report.

Authors:  H Matsui; M Kanamori; Y Abe; T Sakai; K Wakaki
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

10.  Progestin and oestrogen receptors in meningiomas. Biochemical characterization, clinical and pathological correlations in 42 cases.

Authors:  H Magdelenat; B F Pertuiset; M Poisson; P M Martin; J Philippon; B Pertuiset; A Buge
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.